--Low Rate Initial Production/Manufacture of Adenovirus Vaccine Types 4 and 7

The United States Army Medical Research Acquisition Activity (USAMRAA) is issuing an Intent to Procure via Sole Source the award of a Low Rate Initial Production (LRIP) contract with Barr Laboratories for the manufacture, test and release of tableted Adenovirus Vaccine Types 4 and 7. The LRIP contract shall be initiated following submission of the Biologics License Application (BLA) to the FDA. A solicitation is not available. Inquiries should be directed to Mrs. Donna Blackstone via e-mail at donn [email protected].